SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peiwen Chen, Matilde Cescon, Paolo Bonaldo, Autophagy-mediated regulation of macrophages and its applications for cancer, Autophagy, 2014, 10, 2, 192

    CrossRef

  2. 2
    Elodie Viry, Jerome Paggetti, Joanna Baginska, Takouhie Mgrditchian, Guy Berchem, Etienne Moussay, Bassam Janji, Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity, Biochemical Pharmacology, 2014,

    CrossRef

  3. 3
    Isao Okazaki, Takuji Noro, Nobuhiro Tsutsui, Eigoro Yamanouchi, Hajime Kuroda, Masayuki Nakano, Hiroaki Yokomori, Yutaka Inagaki, Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs), Cancers, 2014, 6, 3, 1220

    CrossRef

  4. 4
    G. D. Kennedy, M. Nukaya, S. M. Moran, E. Glover, S. Weinberg, S. Balbo, S. S. Hecht, H. C. Pitot, N. R. Drinkwater, C. A. Bradfield, Liver Tumor Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Dependent on the Aryl Hydrocarbon Receptor and TNF/IL-1 Receptors, Toxicological Sciences, 2014, 140, 1, 135

    CrossRef

  5. 5
    Badr Alzahrani, Tristan J. Iseli, Lionel W. Hebbard, Non-viral causes of liver cancer: Does obesity led inflammation play a role?, Cancer Letters, 2014, 345, 2, 223

    CrossRef

  6. 6
    Thomas C Wirth, Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies, Expert Review of Gastroenterology & Hepatology, 2014, 8, 1, 101

    CrossRef

  7. 7
    Ke Li, Xiao-Xi Lv, Fang Hua, Heng Lin, Wei Sun, Wen-Bin Cao, Xiao-Ming Fu, Jing Xie, Jiao-Jiao Yu, Zhe Li, Hong Liu, Ming-Zhe Han, Zhuo-Wei Hu, Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide, International Journal of Cancer, 2014, 134, 3
  8. 8
    J-P Pradere, D H Dapito, R F Schwabe, The Yin and Yang of Toll-like receptors in cancer, Oncogene, 2014, 33, 27, 3485

    CrossRef

  9. 9
    Lingling Ji, Ruyi Xue, Wenqing Tang, Weibin Wu, Tingting Hu, Xijun Liu, Xiaomin Peng, Jianxin Gu, She Chen, Si Zhang, Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways, FEBS Letters, 2014, 588, 12, 2095

    CrossRef

  10. 10
    Dan Hu, James Denney, Manfei Liang, Avani Javer, Xiaohua Yang, Ruiliang Zhu, Deling Yin, Stimulatory Toll-like receptor 2 suppresses restraint stress-induced immune suppression, Cellular Immunology, 2013, 283, 1-2, 18

    CrossRef

  11. 11
    Ziyan Wang, Jun Yan, Heng Lin, Fang Hua, Xiaoxing Wang, Hanzhi Liu, Xiaoxi Lv, Jiaojiao Yu, Su Mi, Jiaping Wang, Zhuo-Wei Hu, Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice, Hepatology, 2013, 57, 5
  12. 12
    Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial Watch: Toll-like receptor agonists for cancer therapy, OncoImmunology, 2013, 2, 8, e25238

    CrossRef